7, July 2019, pp
Recharge your cells, improve cognitive function, and optimize your health with our advanced therapies
The multicenter, randomized, open-label SURMOUNT-5 trial evaluated the efficacy and safety of Lillys tirzepatide, marketed as Zepbound, and Novos semaglutide, marketed as Wegovy, in adults with obesity, or overweight with at least one of the following comorbidities: hypertension, dyslipidemia, obstructive sleep apnea (OSA) or cardiovascular disease, who did not have diabetes
Breaking the Nausea Cycle One common trap people fall into is not eating because of nausea, which then makes the nausea worse, which further reduces the desire to eat
Radoshitzky SR, Longobardi LE, Kuhn JH, Retterer C, Dong L, Clester JC, et al
These injections can target the fat under the chin to help create a more defined jawline